PHARMA CONGRESS OVERVIEW/AT-A-GLANCE
|
|
FEATURING PRECONFERENCE SESSIONS
|
- Compliance Basics
- Auditing and Monitoring Boot Camp
- Ethical Decision Making Workshop
- Chief Compliance Officer (or designee) Summit (Invitation Only)
|
|
|
|
PLENARY SESSIONS
|
- Chief Compliance Officer Roundtable
- Interactive Dialogue on Compliance Issues via Discussion and Audience Response System
- AUSA Roundtable
- Keynote: OIG Update
- Keynote: FDA-OPDP Update
- Keynote: PhRMA Update
- Keynote: Pharma Compliance: A Global Business Perspective
- Views from the C-suite: The Role of Compliance in HR, R&D and Sales & Marketing
- State Disclosure Laws, Federal Sunshine Act and Global Transparency Initiatives
- Lessons Learned from Public Service
|
|
POSTCONFERENCE SESSION
|
- Compliance as a Strategic Function
|
|
PHARMA CONGRESS IS
|
|
|
|
|
AND THE FOLLOWING MINI SUMMITS
|
- Adult Learning and Leading as a Compliance Professional
- Anticorruption Update, Including FCPA and UK Bribery Act
- Handling Parallel Criminal, Civil and Administrative Investigations
- Sunshine in Depth
- How to Grow a Chief Compliance Officer
- Managing Third Party Relationship Risks
- Government Pricing Update
- Changes to the Commercial Business Model: Defining & Measuring Value to the Patient
- OIG Increases Auditing of Pharmaceutical Manufacturers
- Fair Market Value Update
- Compliance in Commercial Operations Update
- Off-label Promotion: Will the Government Take the First Amendment Seriously?
- Life Sciences Privacy and Data Protection Issues Update
- Ethics and Compliance: Laughter is Still the Best Medicine
- The Interplay between Company Culture and Compliance
- Changes to the Commercial Business Model: Defining the Customer & Influencer
- Emerging Pharma Compliance Issues in the Technology Space
- Update on Data Sharing/Data Transparency in Clinical Trials
- How to Build a Robust and Sustainable Compliance Organization
- Medical Device Compliance Issues Update
- HCP Compliance re On-label vs. Off-label Marketing
- Blowing the Whistle on cGMPs: The Next Big Challenge for Compliance
- Global Compliance Update
- Changes to the Commercial Business Model: New Landscape of Disruptive Technology & Big Data
|
|
|
Who Should Attend
|
- Pharmaceutical and Health Care Executives and Board Members
- Compliance Executives
- Health Plan, Health System and Physician Organizations
- Medical Directors
- Physicians
- Pharmacists and Pharmacy Technicians
- Purchasers, including Private Employers and Public Purchasers
- Pharmaceutical Manufacturers
- Generic Pharmaceutical Manufacturers
- Site Management Organizations
- Clinical Research Organizations
- Pharmacy Benefit Management Companies
|
- Nurses
- Health Plans and Health Insurers
- Wholesale, Retail, Mail Order and Internet Pharmacies
- Health Care Attorneys and In-house Counsel
- Compliance Officers
- Privacy Officers
- Ethics Officers
- Food and Drug Law Attorneys
- Pharmaceutical Consultants
- Investment Bankers
- Venture Capitalists
- Health Care Regulators and Policy Makers
- Health Services Researchers and Academics
- Auditors
|
About the Pharmaceutical Compliance Forum
|
|
The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest researchbased pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. The members meet twice a year, for two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field. PCF also sponsors a three-day compliance congress each Fall. For membership information, contact Kelly Freeman via email at kbfreeman@lilly.com. Please visit their website at www.PharmaComplianceForum.org.
|
